[Progress in virostatic therapy].
D000963:Antimetabolites / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001667:Binding, Competitive; D004267:DNA Viruses / Q000187:drug effects; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007372:Interferons / Q000096:biosynthesis; D008720:Methisazone / Q000627:therapeutic use; D012899:Smallpox / Q000517:prevention & control; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000963:Antimetabolites; D000998:Antiviral Agents; D007372:Interferons; D014740:Vidarabine; D008720:Methisazone; D007065:Idoxuridine
Fortschritte in der virostatischen Therapie.